z-logo
open-access-imgOpen Access
In vivo anti–nociceptive and anti–inflammatory activities of Lippia alba
Author(s) -
Sourav Haldar,
Biswakanth Kar,
Narayan Dolai,
Rajesh Kumar,
Biswaranjan Behera,
Pallab Kanti Haldar
Publication year - 2012
Publication title -
asian pacific journal of tropical disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.208
H-Index - 33
ISSN - 2222-1808
DOI - 10.1016/s2222-1808(12)60241-2
Subject(s) - petroleum ether , lippia , nociception , traditional medicine , carrageenan , in vivo , verbenaceae , chloroform , chemistry , rosa × damascena , pharmacology , anti inflammatory , extraction (chemistry) , essential oil , medicine , chromatography , biology , biochemistry , microbiology and biotechnology , receptor
Objective: To evaluate antinociceptive and anti-inflammatory activities of Lippia alba (Mill.) N.E.\udBrown (Verbenaceae) leaves. Methods: Soxhlet extraction method was used to obtain extracts\udusing petroleum ether extracts (PELA); chloroform extracts (CELA); ethanol extracts (EELA) and\udaqueous extract (AELA). Antinociceptive activity was assessed on rats by tail flick latency using\udtail immersion method and anti-inflammatory activity was estimated by carrageenan induced\udpaw edema method. PELA, CELA and AELA at a dose of 500 mg /kg.b.wt. and EELA at a dose of\ud460 mg /kg.b.wt were administered orally. Result: Competing to control AELA was found to have\uda higher range of anti-nociceptive activity and showing maximum (79.66%) response at 60 min,\udwhere as CELA and EELA were found to have a maximum range of anti-inflammatory activity\udand CELA exhibit maximum (19.5%) response at 240 min. Conclusion: The results suggest that the\udextracts of Lippia alba possess ant-inociceptive and anti-inflammatory activities, and its help to\udauthenticates the use of the plant in the traditional treatment of ailments associated with pain and\udinflammation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here